Volume : 10, Issue : 06, June – 2023
Title:
46.A SHORT REVIEW ON OCCURRENCE OF PHARMACEUTICAL PRODUCTS IN DRINKING WATER
Authors :
Dr. K S Arun Kumar and P V N S H Vardhini*
Abstract :
The presence of various types of pharmaceutical substances and organic pollutants in significant amounts and in traces were reported by many researchers globally. India in the past few decades has grown as one of the top five large scale producers of low-cost pharmaceutical products. More than 50% of revenue generated by Indian large scale and small-scale industries is through exports to developed countries like the United States of America. These pharmaceutical companies dispose of complex and non-biodegradable wastes into the environment, especially water resources which are either untreated or partially treated, therefore contaminating the aquatic ecosystem. These pharmaceutical products reach the ground and surface water easily through various routes such as waste water treatment plants (WTPs), pharmaceutical industries, hospital services, and through human and animal excreta and due to improper disposal of unused and expired medications. Regulatory bodies should frequently monitor the impact of these pharmaceutical products and micro pollutants on human health and aquatic ecosystems. Laws should be enforced for disposal of pharmaceutical and personal care products to prevent contamination of water bodies by employing advanced analytical detection methods like gas and liquid chromatography with mass spectrometry (GC-MS and LC-MS) to determine very low concentrations of pharmaceuticals in ng/L level. Drugs like Atenolol (β-blocker) and Amoxicillin (penicillin antibiotic) are excreted as such unmetabolized were detected in wastewater influent in study conducted in the UK. There is no or limited data in assessing the potential harm and health risks from exposure to these pharmaceutical products in water. No standardised protocol was laid to determine these pharmaceutical pollutants analytically. This present review is aimed in focusing on the pharmaceutical pollution of different water bodies by pharmaceutical products and their metabolites and highlights the importance of strict enforcement of laws governing prevention and removal of these pharmaceutical wastes based on previously published works.
Keywords: Pharmaceutical products, organic pollutants, wastewater treatment plants (WTPs), water resources and drinking water.
Cite This Article:
Please cite this article in press P V N S H Vardhini et al, A Short Review On Occurrence Of Pharmaceutical Products In Drinking Water., Indo Am. J. P. Sci, 2023; 10 (06).
Number of Downloads : 10
References:
1. World Health Organisation. (2012). “Pharmaceuticals in drinking-water.” Retrieved from https://apps.who.int/iris/rest/bitstreams/96066/retrieve#:~:text=Available%20studies 20have%20a reported%20that,or%2050%20ng%2Fl).
2. Jones OA, Lester JN, Voulvoulis N. Pharmaceuticals: a threat to drinking water? Trends Biotechnol. 2005 Apr;23(4):163-7. doi: 10.1016/j.tibtech.2005.02.001. PMID: 15780706.
3. Mompelat S, Le Bot B, Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int. 2009 Jul;35(5):803-14. doi: 10.1016/j.envint.2008.10.008. Epub 2008 Dec 19. PMID: 19101037.
4. Chander V, Sharma B, Negi V, Aswal RS, Singh P, Singh R, Dobhal R. Pharmaceutical Compounds in Drinking Water. J Xenobiot. 2016 Jun 10;6(1):5774. doi: 10.4081/xeno.2016.5774. PMID: 30701048; PMCID: PMC6324466.
5. Balakrishna K, Rath A, Praveenkumarreddy Y, Guruge KS, Subedi B. A review of the occurrence of pharmaceuticals and personal care products in Indian water bodies. Ecotoxicol Environ Saf. 2017 Mar;137:113-120. doi: 10.1016/j.ecoenv.2016.11.014. Epub 2016 Dec 19. PMID: 27915141.
6. Yang Y, Ok YS, Kim KH, Kwon EE, Tsang YF. Occurrences and removal of pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage treatment plants: A review. Sci Total Environ. 2017 Oct 15;596-597:303-320. doi: 10.1016/j.scitotenv.2017.04.102. Epub 2017 Apr 21. PMID: 28437649.
7. Pinto I, Simões M, Gomes IB. An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities. Antibiotics (Basel). 2022 Nov 25;11(12):1700. doi: 10.3390/antibiotics11121700. PMID: 36551357; PMCID: PMC9774725.
8. Spellman’s standard handbook for wastewater operators. Volume III. Advanced level, 2nd ed. CRC Press.
9. Termed et al., 1999; Behaviour and occurrence of estrogens in municipal sewage treatment plants—1. Investigations in Germany, Canada and Brazil. Science of the Total Environment, 225:81–90.
10. Joss A et al., 2005; Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research, 39:3139–3152.
11. Kim SD et al., 2007; Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Research, 41:1013–1021.
12. Klavarioti M, Mantzavinos D, Kassinos D, 2009; Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environment International, 35:402–417.
13. Khiari D, 2007; Endocrine disruptors, pharmaceuticals, and personal care products in drinking water: an overview of AwwaRF research to date. Denver, CO, Awwa Research Foundation.
14. Petrović M, Gonzalez S, Barceló D. Analysis and removal of emerging contaminants in wastewater and drinking water. Trends Anal Chem 2003;22(10):685–96.
15. Pereira A, Silva L, Laranjeiro C, Pena A. Assessment of Human Pharmaceuticals in Drinking Water Catchments, Tap and Drinking Fountain Waters. Applied Sciences. 2021; 11(15):7062. https://doi.org/10.3390/app11157062.
16. Mutiyar, P., Mittal, A., 2013a. Occurrences and fate of an antibiotic amoxicillin in extended aeration-based sewage treatment plant in Delhi, India: a case study of emerging pollutant. Desalin. Water Treat. 51, 6158–6164.
17. Akiba, M., Senba, H., Otagiri, H., Prabhasankar, V., Taniyasu, S., Yamashita, N., Lee, K., Yamamoto, T., Tsutsui, T., Ian Joshua, D., Balakrishna, K., Bairy, I., Iwata, T., Kusumoto, M., Kannan, K., Guruge, K., 2015. Impact of wastewater from different sources on the prevalence of antimicrobial-resistant Escherichia coli in sewage treatment plants in South India. Ecotoxicol. Environ. Saf. 115, 203–208.
18. Santos, L., Gros, M., Rodriguez-Mozaz, S., Delerue-Matos, C., Pena, A., Barcelo, D., Montenegro, M., 2013. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 461–462, 302–316.
19. Kostich, M., Batt, A., Lazorchak, J., 2014. Concentrations of prioritised pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ. Pollut. 184, 354–359.
20. Santos, L., Araujo, A., Fachini, A., Pena, A., Delerue-Matos, C., Montenegro, M., 2010. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 175, 45–95.
21. Brun, G., Bernier, M., Losier, R., Doe, K., Jackman, P., Lee, H., 2006. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ. Toxicol. Chem. 25, 2163.
22. Guerra, P., Kim, M., Shah, A., Alaee, M., Smyth, S., 2014. Occurrence and fate of antibiotic, antibiotic analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci. Total Environ. 473–474, 235–243.
23. Al-Rifai, J., Gabelish, C., Schafer, A., 2007. Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. Chemosphere 69, 803–815.
24. Verlicchi, P., Al Aukidy, M., Galletti, A., Petrovic, M., Barcelo, D., 2012. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 430, 109–118.
25. Bu, Q., Wang, B., Huang, J., Deng, S., Yu, G., 2013. Pharmaceuticals and personal care products in the aquatic environment in China: a review. J. Hazard. Mater. 262, 189–211.
26. Touraud E, Roig B, Sumpter JP, Coetsier C. Drug residues and endocrine disruptors in drinking water: risk for humans? Int J Hyg Environ Health. 2011 Nov;214(6):437-41. doi: 10.1016/j.ijheh.2011.06.003. Epub 2011 Aug 31. PMID: 21885334.
27. Benotti MJ et al. (2009), Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science & Technology, 43(3):597–603.
28. Huerta-Fontela M, Galceran MT, Ventura F (2011), Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Research, 45:1432–1442.
29. Mons MN, Hoogenboom AC, Noij THM (2003), Pharmaceuticals and drinking water supply in the Netherlands. Nieuwegein, Kiwa Water Research (Kiwa Report No. BTO 2003.040).
</div8